Bariatric Surgery Clinical Trial
Official title:
A Prospective Study to Evaluate the Safety and Feasibility of an Endoluminal-suturing Device (Endomina TM) as an Aid for Afferent Loop Syndrome
Surgery is currently the only effective treatment for morbid obesity and can be divided into
restrictive surgeries (Lap Band and Sleeve gastrectomy), malabsorptive surgeries (Biliary
pancreatic deviation and duodenal switch) or a combination of both (RYGBP).
This latter technique is the most common and most effective surgical procedure performed
worldwide and has been processed to be an effective treatment of morbid obesity and its
complications, achieving excess weight loss of 65 to 80 %; 1-2 years after surgery (1,2).
Morbidity after RYGB includes the candy cane syndrome or afferent loop syndrome. Candy cane
Roux syndrome in patients who have undergone RYGB refers to an excessively long blind
afferent Roux limb at the gastrojejunostomy causing postprandial pain often relieved by
vomiting. It is believed that the blind afferent limb ("candy cane") acts as an obstructed
loop when filled with food (often preferentially), and the distention of the loop causes pain
until the food either spills into the Roux limb or is vomited back out (3).
Patients have been reported presenting as early as three months and as late as 11 years after
their initial RYGB, typically with symptoms of postprandial epigastric pain, nausea,
vomiting, and reflux or food regurgitation (4). The diagnosis is confirmed by upper
gastrointestinal contrast studies or endoscopy. On upper gastrointestinal series, the
afferent limb fills before contrast spills into the Roux limb. On upper endoscopy, the
afferent limb is usually the most direct outlet of the gastrojejunostomy (3).
The treatment is revision bariatric surgery, most commonly laparoscopic resection of the
afferent limb, which ranged in length from 3 to 22 cm in one study (mean of 7.6 cm) (3).
Symptoms resolve after revision surgery in most patients. Surgeons should minimize the length
of the blind afferent loop left at the time of initial RYGB to prevent candy cane Roux
syndrome.
Endomina (Endo Tools Therapeutics, Gosselies, Belgium) is a CE marked device that may be
attached to an endoscope inside the body and allows remote actuation of the device during a
peroral intervention. It offers the possibilities of making transoral full thickness tissue
apposition and may allow performing, via a transoral route, large plications with tight
serosa to serosa apposition.
Surgery is currently the only effective treatment for morbid obesity and can be divided into
restrictive surgeries (Lap Band and Sleeve gastrectomy), malabsorptive surgeries (Biliary
pancreatic deviation and duodenal switch) or a combination of both (RYGBP).
This latter technique is the most common and most effective surgical procedure performed
worldwide and has been processed to be an effective treatment of morbid obesity and its
complications, achieving excess weight loss of 65 to 80 %; 1-2 years after surgery (1,2).
Morbidity after RYGB includes the candy cane syndrome or afferent loop syndrome. Candy cane
Roux syndrome in patients who have undergone RYGB refers to an excessively long blind
afferent Roux limb at the gastrojejunostomy causing postprandial pain often relieved by
vomiting. It is believed that the blind afferent limb ("candy cane") acts as an obstructed
loop when filled with food (often preferentially), and the distention of the loop causes pain
until the food either spills into the Roux limb or is vomited back out (3).
Patients have been reported presenting as early as three months and as late as 11 years after
their initial RYGB, typically with symptoms of postprandial epigastric pain, nausea,
vomiting, and reflux or food regurgitation (4). The diagnosis is confirmed by upper
gastrointestinal contrast studies or endoscopy. On upper gastrointestinal series, the
afferent limb fills before contrast spills into the Roux limb. On upper endoscopy, the
afferent limb is usually the most direct outlet of the gastrojejunostomy (3).
The treatment is revision bariatric surgery, most commonly laparoscopic resection of the
afferent limb, which ranged in length from 3 to 22 cm in one study (mean of 7.6 cm) (3).
Symptoms resolve after revision surgery in most patients. Surgeons should minimize the length
of the blind afferent loop left at the time of initial RYGB to prevent candy cane Roux
syndrome.
Endomina (Endo Tools Therapeutics, Gosselies, Belgium) is a CE marked device that may be
attached to an endoscope inside the body and allows remote actuation of the device during a
peroral intervention. It offers the possibilities of making transoral full thickness tissue
apposition and may allow performing, via a transoral route, large plications with tight
serosa to serosa apposition.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04517591 -
Reducing Sedentary Time in Bariatric: The Take a STAND for Health Study
|
N/A | |
Active, not recruiting |
NCT04433338 -
The PREBA Study: Effect of Preoperative Weight Loss With a 14-day Low-calorie Diet on Surgical Procedure and Outcomes in Patients Undergoing RYGB Surgery
|
N/A | |
Completed |
NCT05854875 -
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
|
N/A | |
Recruiting |
NCT06460233 -
Blood Pressure Changes After Bariatric Surgery
|
||
Completed |
NCT00535600 -
Effects of Bariatric Surgery on Insulin
|
||
Withdrawn |
NCT04771247 -
Endoscopic Cardiac Band Ligation for the Management of Refractory GERD After Laparoscopic Sleeve Gastrectomy
|
N/A | |
Not yet recruiting |
NCT03203161 -
Registry on Obesity Surgery in Adolescents
|
||
Enrolling by invitation |
NCT02552433 -
Complications in Body Contouring Surgery
|
||
Completed |
NCT02525016 -
Safety Profile of IntRAvenous Lidocaine Use in Coelioscopic Bariatric Surgery
|
Phase 3 | |
Recruiting |
NCT01984762 -
Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.
|
N/A | |
Not yet recruiting |
NCT01652105 -
Randomized Trial of Preoperative Diets Before Bariatric Surgery
|
N/A | |
Completed |
NCT00989157 -
Effects of Gastric Bypass on Blood Levels of Duloxetine
|
Phase 3 | |
Completed |
NCT03609632 -
Understanding Hypoglycaemia After Bariatric Surgery
|
N/A | |
Completed |
NCT05454696 -
Online Clinic Pilates Exercises in Patients Undergoing Bariatric Surgery
|
N/A | |
Completed |
NCT04040647 -
Tolerance of Early Postoperative Mobilization and Ambulation
|
||
Recruiting |
NCT04297306 -
Virtual Reality Exercise Gaming in Patients Awaiting Bariatric Surgery
|
N/A | |
Recruiting |
NCT05428618 -
Mobile Application for Bariatric Surgery Patients
|
N/A | |
Not yet recruiting |
NCT03975244 -
Semi-supervised Exercise Program Before Bariatric Surgery
|
N/A | |
Not yet recruiting |
NCT03900481 -
Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity
|
N/A | |
Recruiting |
NCT06218953 -
The Impact of Preoperative Anemia on Postoperative Anemia and Related Nutrient Abnormalities After Bariatric Surgery
|